BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 29177948)

  • 1. Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study.
    Lu H; Lin XS; Yao DM; Zhuang YY; Wen GF; Shi J; Sun YQ
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):401-408. PubMed ID: 29177948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Serum Amyloid A Expression and Disease Control after Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis With Nasal Polyps.
    Lu H; Liu H; Wang K; Shi J; Sun Y
    Ear Nose Throat J; 2024 Jun; 103(6):NP331-NP339. PubMed ID: 34814741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of sinus computed tomography in predicting the response to oral glucocorticoids in chronic rhinosinusitis with nasal polyps].
    Hong HY; Sun YQ; Shi JB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Mar; 54(3):192-197. PubMed ID: 30909339
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps.
    Milara J; Peiró T; Armengot M; Frias S; Morell A; Serrano A; Cortijo J
    J Allergy Clin Immunol; 2015 Feb; 135(2):470-6. PubMed ID: 25159466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps.
    Milara J; Morell A; Ballester B; Armengot M; Morcillo E; Cortijo J
    J Allergy Clin Immunol; 2017 Mar; 139(3):855-862.e13. PubMed ID: 27639937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the relationship between 11β-hydroxysteroid dehydrogenase and glucocorticoid response in nasal polyps].
    Jiang LJ; Zhou M; Deng J; Zuo KJ; Shi JB; Lai YY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Mar; 54(3):198-202. PubMed ID: 30909340
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.
    de Borja Callejas F; Martínez-Antón A; Picado C; Alobid I; Pujols L; Valero A; Roca-Ferrer J; Mullol J
    Laryngoscope; 2015 May; 125(5):E158-67. PubMed ID: 25641502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
    Chen F; Hong H; Sun Y; Hu X; Zhang J; Xu G; Zhao W; Li H; Shi J
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):310-316.e2. PubMed ID: 28870448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant protein A and D in chronic rhinosinusitis with nasal polyposis and corticosteroid response.
    Salman S; Akpinar ME; Yigit O; Gormus U
    Am J Rhinol Allergy; 2012; 26(2):e76-80. PubMed ID: 22487281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy and safety of budesonide inhalation suspension via transnasal nebulization compared with oral corticosteroids in chronic rhinosinusitis with nasal polyps].
    Lou H; Wang C; Zhang L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(9):792-6. PubMed ID: 26281053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps.
    Wang H; Bai J; Ding M; Liu W; Xu R; Zhang J; Shi J; Li H
    Eur Arch Otorhinolaryngol; 2013 May; 270(6):1867-72. PubMed ID: 23247332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps.
    Wu X; Hong H; Zuo K; Han M; Li J; Wen W; Xu G; Miao B; Li H
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):75-81. PubMed ID: 26332237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serum macrophage migration inhibitory factor in preoperative prediction of chronic rhinosinusitis with nasal polyps endotypes.
    Yuan X; Xie S; Jing Q; She Y; Jiang W; Zhang H; Xie Z
    Int Immunopharmacol; 2021 Nov; 100():108084. PubMed ID: 34482268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps.
    Epperson MV; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Int Forum Allergy Rhinol; 2019 Dec; 9(12):1436-1442. PubMed ID: 31609091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients.
    Edward JA; Sanyal M; Ramakrishnan VR; Le W; Nguyen AL; Kingdom TT; Hwang PH; Nayak JV
    Int Forum Allergy Rhinol; 2013 Nov; 3(11):866-76. PubMed ID: 24106221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence.
    Wang G; Li M; Zheng J; Zhan J; Zheng H; Li R; Wei X
    Int Immunopharmacol; 2022 Mar; 104():108515. PubMed ID: 35008009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms underlying glucocorticoid resistance in chronic rhinosinusitis with nasal polyps].
    Zhang YY; Lou HF; Wang CS; Zhang L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):154-160. PubMed ID: 29429191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Therapeutics for Rhinosinusitis with Nasal Polyposis.
    Thomas AJ; Alt JA
    Adv Otorhinolaryngol; 2016; 79():138-47. PubMed ID: 27466856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of subjective and objective assessment of glucocorticoid response in nasal polyps: a preliminary study.
    Zheng R; Wang K; Yang Q; Chen Y; Wang D; Gao W; Zhou M; Cao YJ; Shi J; Sun Y
    Acta Otolaryngol; 2019 Jan; 139(1):57-63. PubMed ID: 30676835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.